Show simple item record

dc.contributor.authorÖzbek, Mustafa
dc.contributor.authorÖztürk, M. Akif
dc.contributor.authorÜreten, Kemal
dc.contributor.authorCeneli, Özcan
dc.contributor.authorErdoğan, Mehmet
dc.contributor.authorHaznedaroğlu, İbrahim C.
dc.date.accessioned2019-12-10T11:20:34Z
dc.date.available2019-12-10T11:20:34Z
dc.date.issued2008
dc.identifier.issn1076-0296
dc.identifier.urihttps://doi.org/10.1177/1076029607304750
dc.identifier.urihttp://hdl.handle.net/11655/15346
dc.description.abstractKlinefelter syndrome (KS) is the most common sex chromosome disorder in men. It may be associated with an increased risk for venous thrombosis and thromboembolism, which is partially explained by hypofibrinolysis due to androgen deficiency. Additional genetic or acquired thrombophilic states have been shown in KS patients complicated with venous thrombosis as isolated case reports. Arterial thrombotic events had not been previously reported in KS. In this study, a young man with KS who developed acute arterial thrombosis during testosterone replacement therapy is presented. He was homozygous for the A1298C mutation of the methylenetetrahydrofolate reductase (MTHFR) gene.
dc.language.isoen
dc.publisherSage Publications Inc
dc.relation.isversionof10.1177/1076029607304750
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHematology
dc.subjectCardiovascular System & Cardiology
dc.titleSevere Arterial Thrombophilia Associated with a Homozygous Mthfr Gene Mutation (A1298C) in a Young Man with Klinefelter Syndrome
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalClinical And Applied Thrombosis-Hemostasis
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume14
dc.identifier.issue3
dc.identifier.startpage369
dc.identifier.endpage371
dc.description.indexWoS
dc.description.indexScopus


Files in this item

This item appears in the following Collection(s)

Show simple item record